NTRB
Nutriband Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.97
+6.04%Year over year
Reported trailing growth
- Revenue
- -24.8%
- EBITDA
- +18.5%
- EBIT
- -31.3%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -0.7%
- EBITDA
- +21.3%
- EBIT
- -24.3%
- Net income
- +21.5%
- EPS
- —
- Free cash flow
- -8.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Apr 1, 2026